Cannabis Bioscience International Holdings, Inc. (CBIH)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 05-31. Amounts in USD.

Revenue TTM

0 150K 300K 450K Q4 '23: 316.8K Q1 '24: 253.1K Q2 '24: 234.2K Q3 '24: 219.4K Q4 '24: 248.8K Q1 '25: 354.9K Q2 '25: 365.4K Q3 '25: 343.9K Q4 '25: 303K Q1 '26: 148.3K Q2 '26: 127.4K Q3 '26: 123.6K Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26 Q3 '26

Gross Profit TTM

0 150K 300K 450K Q4 '23: 223.4K Q1 '24: 197K Q2 '24: 170.2K Q3 '24: 167.7K Q4 '24: 203.2K Q1 '25: 309.8K Q2 '25: 327.6K Q3 '25: 298.5K Q4 '25: 262.9K Q1 '26: 108.4K Q2 '26: 84.8K Q3 '26: 97.4K Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26 Q3 '26

Operating Income TTM

-1.1M -700K -350K 0 350K 700K 1.1M Q4 '23: -983.4K Q1 '24: -920.2K Q2 '24: -831.1K Q3 '24: -706.2K Q4 '24: -460.9K Q1 '25: -381.7K Q2 '25: -346.8K Q3 '25: -316.1K Q4 '25: -421.4K Q1 '26: -398.5K Q2 '26: -434.8K Q3 '26: -398.8K Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26 Q3 '26

Net Income TTM

-1.2M -800K -400K 0 400K 800K 1.2M Q4 '23: -1M Q1 '24: -1M Q2 '24: -906.9K Q3 '24: -791.4K Q4 '24: -651.3K Q1 '25: -545.9K Q2 '25: -501K Q3 '25: -473K Q4 '25: -548.8K Q1 '26: -555.2K Q2 '26: -592.6K Q3 '26: -515.3K Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26 Q3 '26

Cost of Revenue TTM

0 35K 70K 105K Q4 '23: 93.5K Q1 '24: 56K Q2 '24: 64K Q3 '24: 51.7K Q4 '24: 45.6K Q1 '25: 45.1K Q2 '25: 37.9K Q3 '25: 45.4K Q4 '25: 40.1K Q1 '26: 39.9K Q2 '26: 42.6K Q3 '26: 26.2K Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26 Q3 '26

Operating Cash Flow TTM

-750K -500K -250K 0 250K 500K 750K Q2 '24: -684.9K Q3 '24: -492.8K Q4 '24: -479.4K Q1 '25: -435.2K Q2 '25: -286K Q3 '25: -359.8K Q4 '25: -329.6K Q1 '26: -402.9K Q2 '26: -336.3K Q3 '26: -268.1K Q3 '24 Q1 '25 Q3 '25 Q1 '26 Q3 '26

Free Cash Flow TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Shares Outstanding Quarterly

0 4B 8B 12B Q2 '23: 8.1B Q3 '23: 7.9B Q1 '24: 10.3B Q2 '24: 10.3B Q3 '24: 10.4B Q1 '25: 10.5B Q2 '25: 10.5B Q3 '25: 10.7B Q1 '26: 11.6B Q2 '26: 11.6B Q3 '26: 11.6B Q2 '23 Q1 '24 Q3 '24 Q2 '25 Q1 '26 Q3 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.00 -0.00 -0.00 0.00 0.00 0.00 0.00 Q4 '23: -0.00 Q1 '24: -0.00 Q2 '24: -0.00 Q3 '24: -0.00 Q4 '24: -0.00 Q1 '25: -0.00 Q2 '25: -0.00 Q3 '25: -0.00 Q4 '25: -0.00 Q1 '26: -0.00 Q2 '26: -0.00 Q3 '26: -0.00 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26 Q3 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.